Frontlight ResearchEarly access
Friedreich ataxia trials in Canada
1 of 3 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in CanadaLong-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA)
- Where
- Montreal
- Age
- 7 years to 21 years
- People
- 120 worldwide
- Run by
- PTC Therapeutics
See details and how to joinNCT07681713 · EU 2026-526947-37-00